alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Editorial Note on Part 892
Editorial Note: Nomenclature changes to part 892 appear at 73 FR 35341, June 23, 2008.

§ 892.1630 Electrostatic x-ray imaging system. ( a ) *Identification.* An electrostatic x-ray imaging system is a device intended for medical purposes that uses an electrostatic field across a semiconductive plate, a gas-filled chamber, or other similar device to convert a pattern of x-radiation into an electrostatic image and, subsequently, into a visible image. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.
( b ) *Classification.* Class II.
Editorial Note on Part 878
Editorial Note: Nomenclature changes to part 878 appear at 73 FR 35341, June 23, 2008.

§ 878.3910 Noninflatable extremity splint. ( a ) *Identification.* A noninflatable extremity splint is a device intended to immobilize a limb or an extremity. It is not inflatable.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 878.9. If the device is not labeled or otherwise represented as sterile, it is exempt from the current good manufacturing practice requirements of the quality system regulation in part 820 of this chapter, with the exception of § 820.180 of this chapter, with respect to general requirements concerning records, and § 820.198 of this chapter, with respect to complaint files.
[53 FR 23872, June 24, 1988, as amended at 54 FR 13827, Apr. 5, 1989; 65 FR 2317, Jan. 14, 2000]
Editorial Note on Part 870
Editorial Note: Nomenclature changes to part 870 appear at 73 FR 35341, June 23, 2008.

§ 870.2060 Transducer signal amplifier and conditioner. ( a ) *Identification.* A transducer signal amplifier and conditioner is a device used to provide the excitation energy for the transducer and to amplify or condition the signal emitted by the transducer.
( b ) *Classification.* Class II (performance standards).
§ 884.5300 Condom. ( a ) *Identification.* A condom is a sheath which completely covers the penis with a closely fitting membrane. The condom is used for contraceptive and for prophylactic purposes (preventing transmission of sexually transmitted infections). The device may also be used to collect semen to aid in the diagnosis of infertility.
( b ) *Classification.* ( 1 ) Class II (special controls) for condoms made of materials other than natural rubber latex, including natural membrane (skin) or synthetic.
( 2 ) Class II (special controls) for natural rubber latex condoms. The guidance document entitled “Class II Special Controls Guidance Document: Labeling for Natural Rubber Latex Condoms Classified Under 21 CFR 884.5300” will serve as the special control. See § 884.1(e) for the availability of this guidance document.
[73 FR 66538, Nov. 10, 2008]
[Federal Register Volume 75, Number 43 (Friday, March 5, 2010)]
[Notices]
[Page 10244]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-4610]


-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. ER10-792-000]


TC Energy Trading, LLC; Supplemental Notice That Initial Market-
Based Rate Filing Includes Request for Blanket Section 204 
Authorization

February 25, 2010.
    This is a supplemental notice in the above-referenced proceeding of 
TC Energy Trading, LLC's application for market-based rate authority, 
with an accompanying rate tariff, noting that such application includes 
a request for blanket authorization, under 18 CFR part 34, of future 
issuances of securities and assumptions of liability.
    Any person desiring to intervene or to protest should file with the 
Federal Energy Regulatory Commission, 888 First Street, NE., 
Washington, DC 20426, in accordance with Rules 211 and 214 of the 
Commission's Rules of Practice and Procedure (18 CFR 385.211 and 
385.214). Anyone filing a motion to intervene or protest must serve a 
copy of that document on the Applicant.
    Notice is hereby given that the deadline for filing protests with 
regard to the applicant's request for blanket authorization, under 18 
CFR part 34, of future issuances of securities and assumptions of 
liability, is March 17, 2010.
    The Commission encourages electronic submission of protests and 
interventions in lieu of paper, using the FERC Online links at http://www.ferc.gov. To facilitate electronic service, persons with Internet 
access who will eFile a document and/or be listed as a contact for an 
intervenor must create and validate an eRegistration account using the 
eRegistration link. Select the eFiling link to log on and submit the 
intervention or protests.
    Persons unable to file electronically should submit an original and 
14 copies of the intervention or protest to the Federal Energy 
Regulatory Commission, 888 First St. NE., Washington, DC 20426.
    The filings in the above-referenced proceeding are accessible in 
the Commission's eLibrary system by clicking on the appropriate link in 
the above list. They are also available for review in the Commission's 
Public Reference Room in Washington, DC. There is an eSubscription link 
on the Web site that enables subscribers to receive e-mail notification 
when a document is added to a subscribed docket(s). For assistance with 
any FERC Online service, please e-mail <a href="/cdn-cgi/l/email-protection#773132253438191b1e191224020707180503371112051459101801"><span class="__cf_email__" data-cfemail="98deddcadbd7f6f4f1f6fdcbede8e8f7eaecd8fefdeafbb6fff7ee">[email protected]</span></a>. or 
call (866) 208-3676 (toll free). For TTY, call (202) 502-8659.

Kimberly D. Bose,
Secretary.
[FR Doc. 2010-4610 Filed 3-4-10; 8:45 am]
BILLING CODE 6717-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Editorial Note on Part 862
Editorial Note: Nomenclature changes to part 862 appear at 73 FR 35341, June 23, 2008.

§ 862.3270 Codeine test system. ( a ) *Identification.* A codeine test system is a device intended to measure codeine (a narcotic pain-relieving drug) in serum and urine. Measurements obtained by this device are used in the diagnosis and treatment of codeine use or overdose and in monitoring levels of codeine to ensure appropriate therapy.
( b ) *Classification.* Class II (special controls). A codeine test system is not exempt if it is intended for any use other than employment or insurance testing or is intended for Federal drug testing programs. The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9, provided the test system is intended for employment and insurance testing and includes a statement in the labeling that the device is intended solely for use in employment and insurance testing, and does not include devices intended for Federal drug testing programs (*e.g.,* programs run by the Substance Abuse and Mental Health Services Administration (SAMHSA), the Department of Transportation (DOT), and the U.S. military).
[52 FR 16122, May 1, 1987, as amended at 84 FR 71798, Dec. 30, 2019]
Editorial Note on Part 886
Editorial Note: Nomenclature changes to part 886 appear at 73 FR 35341, June 23, 2008.

§ 886.5900 Electronic vision aid. ( a ) *Identification.* An electronic vision aid is an AC-powered or battery-powered device that consists of an electronic sensor/transducer intended for use by a patient who has impaired vision or blindness to translate visual images of objects into tactile or auditory signals.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 886.9.
[55 FR 48443, Nov. 20, 1990, as amended at 59 FR 63014, Dec. 7, 1994; 66 FR 38814, July 25, 2001]
§ 74.2208 D&C Green No. 8. ( a ) *Identity and specifications.* The color additive D&C Green No. 8 shall conform in identity and specifications to the requirements of § 74.1208(a)(1) and (b).
( b ) *Uses and restrictions.* D&C Green No. 8 may be safely used for coloring externally applied cosmetics in amounts not exceeding 0.01 percent by weight of the finished cosmetic product.
( c ) *Labeling.* The label of the color additive shall conform to the requirements of § 70.25 of this chapter.
( d ) *Certification.* All batches of D&C Green No. 8 shall be certified in accordance with regulations in part 80 of this chapter.
- USGS Home
- Contact						   USGS
- Search 
USGS

- mobile menu barsUSGS Publications Warehouse
    Contact
    Explore recent 
    publications by USGS Authors
    Browse all of Pubs 
    Warehouse by Publication type and year
    FAQS
    Web 
    Service Documentation
    Other 
    Resources
    Descriptions of US Geological Survey Report Series
- USGS Publications Warehouse
- Contact
- Explore recent 
    publications by USGS Authors
- Browse all of Pubs 
    Warehouse by Publication type and year
- FAQS
- Web 
    Service Documentation
- Other 
    Resources
- Descriptions of US Geological Survey Report Series

- USGS Publications 
  Warehouse
- Explore					    
  Explore recent 
    publications by USGS Authors
    Browse all of Pubs 
    Warehouse by Publication type and year
- Explore recent 
    publications by USGS Authors
- Browse all of Pubs 
    Warehouse by Publication type and year
- Documentation					    
  FAQS
    Web 
    Service Documentation
    Other 
    Resources
    Descriptions of US Geological Survey Report Series
- FAQS
- Web 
    Service Documentation
- Other 
    Resources
- Descriptions of US Geological Survey Report Series
- Contact

### On batholiths and volcanoes - intrusion and eruption of late 
Cenozoic magmas in the Glacier Peak area, North Cascades, Washington

#### Professional Paper 604

Tweet


#### Links

- More information: **National Geologic Map Database Index Page**     
                             (html)
- Document: **Document**                                
  (pdf)
- Plate: **Plate 
  1**                                (pdf)
- Download citation as:  RIS

#### Abstract

#### Additional publication details

Part or all of this report is presented in Portable 
Document Format (PDF). For best results viewing and printing PDF documents, it 
is recommended that you download the documents to your computer and open them 
with Adobe Reader. PDF documents opened from your browser may not display or 
print as intended. Download the latest version of Adobe 
Reader, free of charge. More information about viewing, downloading, and 
printing report files can be found here.

Accessibility
				    FOIA				    Privacy				    Policies and 
Notices

U.S. Department of the Interior				    | 				    
U.S. Geological 
Survey				    				   URL: http://pubs.er.usgs.gov/publication/pp604 
                   				    				   Page Contact Information: Pubs 
Warehouse Contact Page				    				   Page Last Modified: February 02, 
2012 00:06:03
Editorial Note on Part 878
Editorial Note: Nomenclature changes to part 878 appear at 73 FR 35341, June 23, 2008.

§ 878.3610 Esophageal prosthesis. ( a ) *Identification.* An esophageal prosthesis is a rigid, flexible, or expandable tubular device made of a plastic, metal, or polymeric material that is intended to be implanted to restore the structure and/or function of the esophagus. The metal esophageal prosthesis may be uncovered or covered with a polymeric material. This device may also include a device delivery system.
( b ) *Classification.* Class II. The special control for this device is FDA's “Guidance for the Content of Premarket Notification Submissions for Esophageal and Tracheal Prostheses.”
[65 FR 17145, Mar. 31, 2000]
<Page>

INDEPENDENT AUDITORS' CONSENT

We consent to the use in this Pre-Effective Amendment No. 1 to Registration
Statement No. 333-101928 of Hartford Life and Annuity Insurance Company
Separate Account Three of our report dated March 26, 2003, relating to the
financial statements of Hartford Life and Annuity Insurance Company, and of
our report dated February 21, 2003, relating to the financial statements of
Hartford Life and Annuity Insurance Company Separate Account Three, appearing
in the Statement of Additional Information, which is a part of such
Registration Statement, and to the reference to us under the heading
"Independent Public Accountants" in such Statement of Additional Information.

Deloitte & Touche LLP

Hartford, Connecticut

April 7, 2003
[Federal Register Volume 75, Number 46 (Wednesday, March 10, 2010)]
[Notices]
[Page 11105]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-4955]


-----------------------------------------------------------------------

DEPARTMENT OF AGRICULTURE

Forest Service


Notice of Central Idaho Resource Advisory Committee Meeting

AGENCY: Forest Service, USDA.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: Pursuant to the authorities in the Federal Advisory Committee 
Act (Pub. L. 92-463) and under the Secure Rural Schools and Community 
Self Determination Act of 2000 (Pub. L. 110-343), the Salmon-Challis 
National Forest's Central Idaho Resource Advisory Committee will 
conduct a business meeting which is open to the public.

DATES: Tuesday, March 23, 2010, beginning at 4 p.m.

ADDRESSES: Salmon-Challis N.F. South Zone Office, Highway 93, Challis, 
Idaho.

SUPPLEMENTARY INFORMATION: Agenda topics will include review of RAC 
2010 projects, approval of RAC project proposals, and other RAC 
business. The meeting is an open public forum. Some RAC members may 
attend the meeting by conference call, telephone, or electronically.

FOR FURTHER INFORMATION CONTACT: Lyle E. Powers, Acting Forest 
Supervisor and Designated Federal Officer, at 208-756-5557.

    Dated: March 2, 2010.
Frank V. Guzman,
Forest Supervisor, Salmon-Challis National Forest.
[FR Doc. 2010-4955 Filed 3-8-10; 8:45 am]
BILLING CODE 3410-11-M
UNPUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT No. 07-1778
MICHAEL L. PACK, Plaintiff - Appellant, versus MAUREEN WALSH DAVID, Assistant Attorney General, Defendant - Appellee. Appeal from the United States District Court for the District of Maryland, at Baltimore. Richard D. Bennett, District Judge. (1:07-cv-02004-RDB) Submitted: October 11, 2007 Decided: October 15, 2007 Before MICHAEL and SHEDD, Circuit Judges, and HAMILTON, Senior Circuit Judge. Dismissed by unpublished per curiam opinion. Michael L. Pack, Appellant Pro Se. Unpublished opinions are not binding precedent in this circuit.- 2 - PER CURIAM: Michael L. Pack appeals the district court’s order dismissing his civil rights complaint under 28 U.S.C. § 1915(e) (2000). We have reviewed the record and find that this appeal is frivolous. Accordingly, we dismiss the appeal for the reasons stated by the district court. See Pack v. David , No. 1:07-cv02004-RDB (D. Md. Aug. 1, 2007). We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

DISMISSED
Editorial Note on Part 872
Editorial Note: Nomenclature changes to part 872 appear at 73 FR 35341, June 23, 2008.

§ 872.3950 Glenoid fossa prosthesis. ( a ) *Identification.* A glenoid fossa prosthesis is a device that is intended to be implanted in the temporomandibular joint to augment a glenoid fossa or to provide an articulation surface for the head of a mandibular condyle.
( b ) *Classification.* Class III.
( c ) *Date PMA or notice of completion of a PDP is required.* A PMA or a notice of completion of a PDP is required to be filed with the Food and Drug Administration on or before March 30, 1999, for any glenoid fossa prosthesis that was in commercial distribution before May 28, 1976, or that has on or before March 30, 1999, been found to be substantially equivalent to a glenoid fossa prosthesis that was in commercial distribution before May 28, 1976. Any other glenoid fossa prosthesis shall have an approved PMA or a declared completed PDP in effect before being placed in commercial distribution.
[59 FR 65478, Dec. 20, 1994, as amended at 63 FR 71746, Dec. 30, 1998]
Editorial Note on Part 868
Editorial Note: Nomenclature changes to part 868 appear at 73 FR 35341, June 23, 2008.

§ 868.6250 Portable air compressor. ( a ) *Identification.* A portable air compressor is a device intended to provide compressed air for medical purposes, e.g., to drive ventilators and other respiratory devices.
( b ) *Classification.* Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 868.9.
[47 FR 31142, July 16, 1982, as amended at 84 FR 71811, Dec. 30, 2019]
Editorial Note on Part 890
Editorial Note: Nomenclature changes to part 890 appear at 73 FR 35341, June 23, 2008.

§ 890.1225 Chronaximeter. ( a ) *Identification.* A chronaximeter is a device intended for medical purposes to measure neuromuscular excitability by means of a strength-duration curve that provides a basis for diagnosis and prognosis of neurological dysfunction.
( b ) *Classification.* Class II (performance standards).
CLIMACHEM, INC





ClimaChem, Inc.


16 South Pennsylvania  Oklahoma City, OK  73107  405-235-4546 
 Fax: 405-236-1209



March 3, 2003  






Todd L. Boehly, Managing Director

Guggenheim Partners

135 East 57th Street, 9th Floor

New York, New York 10022



RE:Securities Purchase Agreement (the "SPA"), dated as of May 24, 2002, as amended, by and among ClimaChem, Inc. ("ClimaChem"), certain subsidiaries of ClimaChem, LSB Industries, Inc., as guarantor, the Purchasers identified therein
 and Guggenheim Investment Management, LLC, as Collateral Agent9;






Dear Todd:



This letter shall serve to document the consent by Guggenheim Investment Management, LLC, as collateral agent and the Purchasers that are party to the SPA, to the increase in Capital Expenditures, as defined under the SPA, to $11,240,000 for the 12-month period ending each fiscal quarter after the date of the SPA.  Please confirm your consent to the foregoing by signing below where indicated.  Thank you.




                                                                        Sincerely,





                                                                        David M. Shear

                                                                        General Counsel







AGREED TO AND ACKNOWLEDGED:









_____________________________________

Todd L. Boehly, Managing Director for 

the Purchasers and Collateral Agent
March 21, 2003

Frederick L. Bowman
President
Portland Brewing Company
2730 NW 31st Avenue
Portland, Oregon  97210

Re: Portland Brewing Company ("Company")

Dear Fred:

To the extent that the Company incurs working capital deficiencies in 2003, MLP
will provide funding to the Company in the form of debt or equity in an amount
not to exceed $500,000 to remedy cash deficiencies that may be necessary to fund
operations through December 31, 2003.

This agreement is binding and non-cancelable.

Very Truly Yours,


/s/ ROBERT M. MACTARNAHAN
-------------------------
Robert M. MacTarnahan
On Behalf of MacTarnahan Limited Partnership,
Harmer Mill & Logging Co., Robert M. MacTarnahan


Acknowledged:

/s/ FREDERICK L. BOWMAN
-------------------------
By: Frederick L. Bowman
Chairman & President


Cc:  Chris Hansen, Moss Adams LLP
* Pursuant to 5TH CIR. R. 47.5, the court has determined that

this opinion should not be published and is not precedent except

under the limited circumstances set forth in 5TH CIR. R. 47.5.4.

United States Court of Appeals

Fifth Circuit

FILED

April 11, 2006

Charles R. Fulbruge III

Clerk

IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

No. 05-40983

Conference Calendar

RUBEN ROCHA,

Petitioner-Appellant,

versus

RUDY CHILDRESS, Warden,

Respondent-Appellee.

--------------------

Appeal from the United States District Court

for the Eastern District of Texas

USDC No. 1:04-CV-668 

--------------------

Before JONES, Chief Judge, and JOLLY and DAVIS, Circuit Judges.

PER CURIAM:*

Ruben Rocha, federal prisoner # 18815-077, appeals the

district court’s dismissal of his 28 U.S.C. § 2241 petition,

wherein he challenged his conviction for using or carrying a

firearm during commission of a crime of violence, in violation of

18 U.S.C. § 924(c). Rocha challenged his conviction based on

Bailey v. United States, 516 U.S. 137 (1995).

Rocha argues that his challenge to the firearms offense

falls within the savings clause of 28 U.S.C. § 2255. “[T]he
No. 05-40983

-2-

savings clause of § 2255 applies to a claim (i) that is based on

a retroactively applicable Supreme Court decision which

establishes that the petitioner may have been convicted of a

nonexistent offense and (ii) that was foreclosed by circuit law

at the time when the claim should have been raised in the

petitioner’s trial, appeal, or first § 2255 motion.” 

Reyes-Requena v. United States, 243 F.3d 893, 904 (5th Cir.

2001).

This court has already held that the evidence was sufficient

to support Rocha’s conviction for carrying a firearm under 

§ 924(c). See United States v. Rocha, 916 F.2d 219, 236-37 (5th

Cir. 1990). We have also held that this prior holding precludes

Rocha from seeking the application of the savings clause under 

§ 2255. See United States v. Rocha, 2002 WL 31049460 at *1 (5th

Cir. Sept. 3, 2002). Rocha has not shown that he meets the first

prong of the Reyes-Requena test. See Reyes-Requena, 243 F.3d at

904.

Accordingly, the district court’s judgment is AFFIRMED.
Exhibit 3.3

                            CERTIFICATE OF FORMATION

                                       OF

                                 PSEG FOSSIL LLC

            This Certificate of Formation of PSEG Fossil LLC (the "LLC"), dated
as of June 16, 1999, is being duly executed and filed by Bernard J. Kelley, as
an authorized person, to form a limited liability company under the Delaware
Limited Liability Company Act (6 Del.C. subsection 18-101, et seq.).

            FIRST. The name of the limited liability company formed hereby is
PSEG Fossil LLC.

            SECOND. The address of the registered office of the LLC in the State
of Delaware is c/o The Corporation Trust Company, 1209 Orange Street,
Wilmington, New Castle County, Delaware 19801.

            THIRD. The name and address of the registered agent for service of
process on the LLC in the State of Delaware is The Corporation Trust Company,
1209 Orange Street, Wilmington, New Castle County, Delaware 19801.

            IN WITNESS WHEREOF, the undersigned has executed this Certificate of
Formation as of the date first above written.

                                                       /s/ Bernard J. Kelley
                                                       -----------------------
                                                       Name: Bernard J. Kelley
                                                       Authorized Person